Clinical Trial Update: Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating a combination of acarbose, metformin, and sitagliptin in patients with type 2 diabetes mellitus has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Acarbose (acarbose)
• Sitagliptin (sitagliptin)
• metformin (metformin)

Snippet

Sponsor: The Catholic University of Korea | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2020-08-17